What challenges did Iktos face before AI implementation?

Drug-discovery workflows are complex to configure for medicinal chemists. Integrating multiple software systems for molecule optimization and synthesis is difficult. The company needed a way to make AI software easier to use in specific workflow contexts.

What was the impact of the AI solution?

Iktos says its robotic system can do the job of 30 chemists. The company says medicinal chemistry timelines can be reduced from five years to two or three years depending on the project. Iktos reports the approach is aimed at faster end-to-end chemistry and better lab productivity.

Source

Iktos uses AI and robotics to accelerate drug discovery

Use case typeAI platformUpdated Jun 13, 2026

Iktos uses AI and robotics to accelerate drug discovery. Founded in 2016, Iktos builds software and robotics for end-to-end drug-discovery workflows, including molecular design, synthesis planning, and autonomous molecule creation.

Organization: Iktos
Industry: Pharma
Location: France
Published: May 2026

Reported outcomes

Strategic outcomes

Scale & capacityAutomated work of 30 chemistsSpeed & agilityAccelerated drug discovery timelinesNew product / capabilityAdded conversational workflow assistanceNew product / capabilityIntroduced AI agents for software configuration

Primary read

Use case focus

Showing 3 of 3

1Generative AI
2Workflow Automation
3Conversational AI

Drug-discovery workflows are complex to configure for medicinal chemists.
Integrating multiple software systems for molecule optimization and synthesis is difficult.
The company needed a way to make AI software easier to use in specific workflow contexts.

Iktos moved its software stack to AWS and uses a hybrid architecture to connect heterogeneous vendor software securely.
The company plans to use Amazon Bedrock to add conversational AI and context-aware assistance so users can understand what to do in a given workflow context.
Iktos is also looking at AI agents to help configure software for medicinal chemists who may not know how AI should be configured.

Technologies

Amazon Bedrock

Iktos says its robotic system can do the job of 30 chemists.
The company says medicinal chemistry timelines can be reduced from five years to two or three years depending on the project.
Iktos reports the approach is aimed at faster end-to-end chemistry and better lab productivity.

Architecture

Iktos describes a hybrid AWS-connected software architecture for integrating multiple vendor systems. The article also mentions a robotic lab system and plans to use Amazon Bedrock for conversational AI assistance in workflow context; the robot is not directly connected into AWS, but the software driving it is.

Sources & evidence1

Groundedness: 5/5Type: Customer StoryPublished: May 27, 2026Publisher: AWSEvidence: PrimaryConfidence: High

Primary source

AI-generated summary. Verify important details with the linked sources before relying on this case.

Explore related AI use cases

Customer evidence